Prevention of breast milk transmission of HIV: The time is now

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 3, 2009, Pages 305-308

  Mofenson, Lynne M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

BREAST FEEDING; BREAST MILK; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PERINATAL PERIOD; POSTNATAL CARE; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; PREGNANCY;

EID: 70350532585     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181bbfe14     Document Type: Editorial

References (28)

1. Townsend CL, Cortina-Boria M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-981.
2. Kuhn L, Reitz C, Abrams EJ. Breastfeeding and AIDS in the developing world. Curr Opin Pediatr. 2009;21:83-93.
3. UNAIDS. 2007 AIDS epidemic update. Available at: http://data.unaids. org/pub/EPISlides/2007/2007-epiupdate-en.pdf. Accessed August 7, 2009.
4. Newell ML. Current issues in the prevention of mother to child transmission of HIV-1 infection. Trans R Soc Trop Med Hyg. 2006;100:1-5.
5. Arpadi S, Fawzy A, Aldrovandi GM, et al. Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr. 2009;90:344-353.
6. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008;359:130-141.
7. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296:794-805.
8. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107-1116.
9. Kuhn L, Aldrovandi G, Sinkala M, et al. High uptake of exclusive breastfeeding and reduced post-natal HIV transmission: prospective results from the Zambia exclusive breastfeeding study. 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Sydney, Australia, 22-25 July 2007 (abstract TuAX103).
10. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: The Mitra Plus study. JAIDS. 2009;52:406-416
11. The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomized, double-blind, placebo-controlled trial. Lancet. 1999;353:1178-1186.
12. Thomas T, Masaba R, Ndivo R, et al. PMTCT of HIV-1 among breastfeeding women using HAART: the Kisumu Breastfeeding Study, Kisumu, Kenya, 2003-2007 (45aLB). Presented at: 15th Conference on Retroviruses and Opportunistic Infections; 2008; Boston, MA.
13. Arendt V, Ndimubanzi P, Vyankandondera J, et al. AMATA study: effectiveness of antiretroviral therapy in breastfeeding mothers to prevent post-natal vertical transmission in Rwanda (TuAX102). Presented at: 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 2007; Sydney, Australia.
14. Palombi L, Marazzi MC, Voetberg A, et al. Treatment acceleration program and the experience of the DREAM program in prevention of mother to child transmission of HIV. AIDS. 2007;21(Suppl 4):S65-S71.
15. Kilewo C, Karlsson K, Massawe A, et al. Mitra Study Team. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. JAIDS. 2008;48:315-323.
16. Six Week Extended-Dose Nevirapine (SWEN) Study Team, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia India and Uganda: an analysis of three randomised controlled trials. Lancet 2008, 372:300-313.
17. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129.
18. De Vincenzi I, Kesho Bora Study Group. Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa (LBPE C01). Presented at: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; 2009; Capetown, South Africa.
19. Shapiro R, Hughes M, Ogwu A, et al. The Mma Bana Study: randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and the prevention of mother-to-child HIV transmission among breastfeeding Women in Botswana (WeLB B101). Presented at: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; 2009; Capetown, South Africa.
20. Chasela C, Hudgens M, Jaimeson D, et al. Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study (WeLB C103). Presented at: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; 2009; Capetown, South Africa.
21. De Vincenzi I, Kesho Bora Study Group. HIV-free survival at 12 months among children born to HIV-infected women receiving antiretrovirals from 34 to 36 weeks of pregnancy (638). Presented at: 15th Conference on Retroviruses and Opportunistic Infections; 2008; Boston, MA.
22. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of extended infant antiretroviral prophylaxis and effect of maternal HAART. J Infect Dis. 2009; In press.
23. Moorthy A, Gupta A, Bhosale R. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One. 2009;4: e4096.
24. Zeh C, Weidle P, Nafisa L, et al. Emergence of HIV-1 drug resistance among breastfeeding infants born to HIV-infected mothers taking antiretrovirals for prevention of mother-to-child transmission of HIV: The Kisumu Breastfeeding Study, Kenya (84LB). Presented at: 15th Conference on Retroviruses and Opportunistic Infections; 2008; Boston, MA.
25. Kafulafula G, Thigpen M, Hoover D, et al. Post-weaning gastroenteritis and mortality among HIV-uninfected African infants receiving ARV prophylaxis to prevent MTCT of HIV-1 (773). Presented at: 14th Conference on Retroviruses and Opportunistic Infections; 2007; San Francisco, CA.
26. Fawzy A, Arpadi S, Aldrovandi G, et al, Zambia Exclusive Breastfeeding Study Group. Diarrhea morbidity and mortality increases with weaning prior to 6 months among uninfected infants born to HIV-infected mothers in Zambia (TuA C104). Presented at: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; 2009; Capetown, South Africa.
27. Shapiro RL, Lockman S, Kim S, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breastfeeding HIV-infected and uninfected women in Botswana. J Infect Dis. 2007;196:562-569.
28. Kuhn L, Aldrovandi GM, Sinkala M, et al. Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS One. 2009;4:e6059.